|
|
|
Volumn 9, Issue 2, 1999, Pages 104-109
|
|
Journal club common HIV drug-drug interactions
|
|
Author keywords
Drug interactions; Drug toxicity; Pharmacodynamics; Pharmacokinetics; Protease inhibitor; Therapy, AIDS
|
|
Indexed keywords
ACICLOVIR;
ALBUMIN;
ANTACID AGENT;
ANTIDEPRESSANT AGENT;
ANTIFUNGAL AGENT;
ANTIRETROVIRUS AGENT;
CALCIUM;
CIDOFOVIR;
CIPROFLOXACIN;
CYTOCHROME P450;
DIDANOSINE;
GANCICLOVIR;
INDINAVIR;
KETOCONAZOLE;
LAMIVUDINE;
LEVOFLOXACIN;
MAGNESIUM;
NELFINAVIR;
PHENOBARBITAL;
PHENYTOIN;
PROBENECID;
PROTEINASE INHIBITOR;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
RIFAMYCIN;
RITONAVIR;
SAQUINAVIR;
TROVAFLOXACIN;
UNINDEXED DRUG;
ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ARTICLE;
BONE MARROW SUPPRESSION;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG MONITORING;
FOOD DRUG INTERACTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
NEPHROTOXICITY;
POLYPHARMACY;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DRUG INTERACTION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
DRUG INTERACTIONS;
DRUG MONITORING;
HIV PROTEASE INHIBITORS;
HUMANS;
|
|
EID: 0033004538
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (8)
|
